Innoviva (INVA) Tops Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts INVA Hot Sheet
Join SI Premium – FREE
Innoviva (NASDAQ: INVA) reported Q4 EPS of $0.26, $0.07 better than the analyst estimate of $0.19. Revenue for the quarter came in at $43.6 million versus the consensus estimate of $40.72 million.
For earnings history and earnings-related data on Innoviva (INVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Aytu BioScience (AYTU) Tops Q4 EPS by 28c
- Ennis (EBF) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
